Martin Alexander Maier
CIK: 0002116511
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRQR
ProQR Therapeutics N.V.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Maier Martin Alexander
Maier Martin Alexander (SEC CIK 0002116511) files insider reports with the SEC as Director of ProQR Therapeutics N.V. (PRQR).
Signal8 holds 1 ownership filing by Maier Martin Alexander, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Maier Martin Alexander's filings is in LEIDEN.
Other insiders filing for ProQR Therapeutics N.V. (PRQR)
- de Boer Daniel Anton, Chief Executive Officer
- Filius Bart, Director
- Hinsch Gylvin Lykke, Director
- Valerio Domenico, Director
- Platenburg Gerardus Johannes, Chief Scientific Officer
- Lawton Alison Frances, Director